The original GLP-1 trials paired pharmacotherapy with structured lifestyle support
N Engl J Med 392(6):612615 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Drugs like Wegovy and Zepbound are designed to mimic this natural hormone, offering a potent way to enhance your bodys own regulatory systems
[DOI] [PubMed] [Google Scholar] 45.Volpe S., Lisco G., Fanelli M., Racaniello D., Colaianni V., Triggiani D., Donghia R., Crudele L., Rinaldi R., Sabb C., et al
Klinik kullanmda bu ayrm genellikle uygulama skl ve etki sresine gre yaplr
And we understand that diet and exercise alone arent always enough